Matches in Wikidata for { <http://www.wikidata.org/entity/Q92392242> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92392242 description "clinical trial" @default.
- Q92392242 description "ensayo clínico" @default.
- Q92392242 description "ensayu clínicu" @default.
- Q92392242 description "klinisch onderzoek" @default.
- Q92392242 description "клінічне випробування" @default.
- Q92392242 description "临床试验" @default.
- Q92392242 name "Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors" @default.
- Q92392242 name "Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors" @default.
- Q92392242 type Item @default.
- Q92392242 label "Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors" @default.
- Q92392242 label "Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors" @default.
- Q92392242 prefLabel "Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors" @default.
- Q92392242 prefLabel "Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors" @default.
- Q92392242 P1132 Q92392242-EB792A1B-9532-47A4-98A8-AB531B03C357 @default.
- Q92392242 P1476 Q92392242-2EE6A311-5C43-4F6C-B837-6CD9697E3A49 @default.
- Q92392242 P17 Q92392242-6674EDE9-62E0-4A36-B715-1AFC9301B2DC @default.
- Q92392242 P17 Q92392242-A8C003C9-E755-498C-92EB-840422F38782 @default.
- Q92392242 P2899 Q92392242-13317FAF-EA17-4148-A373-00181625E043 @default.
- Q92392242 P3098 Q92392242-F2AE0920-EE1D-445E-A59E-BE04F6BBFEC7 @default.
- Q92392242 P31 Q92392242-487DA631-B379-48E8-A324-B09D6F9F1B74 @default.
- Q92392242 P4844 Q92392242-136E6E7D-21F2-4620-A3E8-FCF86061D005 @default.
- Q92392242 P4844 Q92392242-38986EF5-7321-4C33-8D78-CEF4C08FE681 @default.
- Q92392242 P580 Q92392242-D0135D1E-89FD-4DB4-AD6E-3EBE8734529E @default.
- Q92392242 P582 Q92392242-3E0C8D29-D5BD-4C75-AAAB-AC692A917215 @default.
- Q92392242 P6099 Q92392242-44EA1490-9F96-47A5-92FA-6F342C918EB3 @default.
- Q92392242 P6099 Q92392242-789C9E7B-79CD-46DF-930D-88359DA5997B @default.
- Q92392242 P8005 Q92392242-73C498D1-190A-4175-8D2F-4B49D8F8D400 @default.
- Q92392242 P8363 Q92392242-1C0374B5-93C5-42C5-963B-8A83947D9B4F @default.
- Q92392242 P859 Q92392242-5A5673E4-A670-4AD6-A029-C57DA0416701 @default.
- Q92392242 P1132 "+308" @default.
- Q92392242 P1476 "A Phase 1/2 Study of BMS-986315 as Monotherapy and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors" @default.
- Q92392242 P17 Q16 @default.
- Q92392242 P17 Q30 @default.
- Q92392242 P2899 "+18" @default.
- Q92392242 P3098 "NCT04349267" @default.
- Q92392242 P31 Q30612 @default.
- Q92392242 P4844 Q420296 @default.
- Q92392242 P4844 Q7041828 @default.
- Q92392242 P580 "2020-05-29T00:00:00Z" @default.
- Q92392242 P582 "2024-04-14T00:00:00Z" @default.
- Q92392242 P6099 Q42824440 @default.
- Q92392242 P6099 Q5452194 @default.
- Q92392242 P8005 Q76649614 @default.
- Q92392242 P8363 Q78089383 @default.
- Q92392242 P859 Q266423 @default.